Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.
4.

Revisions to the requirements applicable to blood, blood components, and source plasma. Final rule.

Food and Drug Administration, HHS.

Fed Regist. 2001 Aug 6;66(151):40886-90.

5.

Revisions to the requirements applicable to blood, blood components and source plasma. Direct final rule.

Food and Drug Administration, HHS.

Fed Regist. 2007 Aug 16;72(158):45883-88.

8.
10.
11.

Standards for the terminology and labeling of cellular therapy products.

Ashford P, Distler P, Gee A, Lankester A, Larsson S, Feller I, Loper K, Pamphilon D, Poston L, Rabe F, Slaper-Cortenbach I, Szczepiorkowski Z, Warkentin P; International Cellular Therapy Coding and Labeling Advisory Group.

J Clin Apher. 2007;22(5):249-57. No abstract available.

PMID:
17823945
12.

Implementing the ISBT 128 labeling standard in a transfusion service.

Tiehen A, Swanson S.

MLO Med Lab Obs. 1998 May;30(5):18-9, 22-3, 26-7. No abstract available.

PMID:
10179684
13.

Unique device identification system. Final rule.

Food and Drug Administration, HHS.

Fed Regist. 2013 Sep 24;78(185):58785-828.

14.
16.

Applying radio-frequency identification (RFID) technology in transfusion medicine.

Hohberger C, Davis R, Briggs L, Gutierrez A, Veeramani D.

Biologicals. 2012 May;40(3):209-13. doi: 10.1016/j.biologicals.2011.10.008. Epub 2011 Nov 10.

PMID:
22079476
17.
20.

Supplemental Content

Support Center